T. Bradshaw
2010
Citations
0
Influential Citations
6
Citations
Journal
The Pharmaceutical Journal
Abstract
Phortress is the result of multidisciplinary research involving pharmacists, chemists, molecular biologists, pharmacologists and clinicians. It is developed under the direction of Malcolm Stevens, inventor of temozolomide (PJ BPC supplement, October 2009, pB26). Phortress is currently in phase I clinical trial at the Northern Institute for Cancer Research at Newcastle University. A second phase I site, at Hammersmith Hospital in London, will begin patient recruitment shortly.